-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
Shi Si Yao: Foreign Trade Sales Remain “Online”
Category:
Time：2020-03-17
On March 16, intravenous infusion products exported by Shijiazhuang Sihua Pharmaceutical Co., Ltd. are being loaded onto trucks. This shipment will be sent to overseas markets.
On March 16, intravenous infusion products exported by Shijiazhuang Sihua Pharmaceutical Co., Ltd. are being loaded onto trucks. This shipment will be sent to overseas markets.
At a time when the COVID-19 pandemic is spreading globally, fulfilling contractual obligations on time and stabilizing foreign trade demonstrate the sense of responsibility of a company that acts with integrity. The Foreign Trade Department of Shijiazhuang Sihua Pharmaceutical has actively responded to the impact of the pandemic by maintaining continuous order acceptance and uninterrupted service through “online-to-online” and “screen-to-screen” interactions, thereby boosting confidence in cooperation. In the first two months of this year, the company’s foreign trade sales continued to post double-digit growth.
“China’s foreign trade demonstrates strong resilience, and the long-term trend of robust development remains unchanged.” Right now, Shijiazhuang Sihua Pharmaceutical is going all out to secure orders and expand markets, striving for a strong start to its foreign trade sales in the first quarter.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Mobile site
E code
Business license